TRELEGY ELLIPTA

Google image searchProduct monograph

Active ingredients

umeclidinium (umeclidinium bromide), 62.5 MCG/ACT

vilanterol (vilanterol trifenatate), 25 MCG/ACT

fluticasone furoate, 100 MCG/ACT

DIN: 02474522

Dosage form(s): POWDER

Route(s) of administration: INHALATION

Schedule: Prescription

Company: GLAXOSMITHKLINE INC

Date: 30-MAY-2018

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03A — ADRENERGICS, INHALANTS (ATC, ATC/DDD)
• R03AL — Adrenergics in combination with anticholinergics (ATC, ATC/DDD)
• R03AL08 — VILANTEROL, UMECLIDINIUM BROMIDE AND FLUTICASONE FUROATE (ATC/DDD)

External Links for Trelegy Ellipta

Search on Google

• Trelegy Ellipta side effects
• Trelegy Ellipta dosage
• umeclidinium side effects
• umeclidinium dosage
• vilanterol side effects
• vilanterol dosage
• fluticasone furoate side effects
• fluticasone furoate dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find trelegy ellipta photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.